INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.98 Cr | ₹0.95 Cr | ₹0.67 Cr | ₹0.59 Cr | - |
What is the latest Contingent Liabilities ratio of INDO US BIOTECH ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.98 Cr |
Mar2023 | ₹0.95 Cr |
Mar2022 | ₹0.67 Cr |
Mar2021 | ₹0.59 Cr |
Mar2020 | - |
How is Contingent Liabilities of INDO US BIOTECH Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.98 Cr | 2.84 | |
Mar2023 | ₹0.95 Cr | 42.64 | |
Mar2022 | ₹0.67 Cr | 13.27 | |
Mar2021 | ₹0.59 Cr | 0 | |
Mar2020 | - | - |
Compare Contingent Liabilities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹518.5 Cr | 2.4% | 9.4% | 9.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹17,603.8 Cr | -1.1% | -6.3% | 66.4% | Stock Analytics | |
KAVERI SEED COMPANY | ₹4,328.3 Cr | 0.4% | -2% | 39.6% | Stock Analytics | |
VENKYS (INDIA) | ₹2,399.4 Cr | 0% | 0.1% | -15.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,474.5 Cr | -4.4% | -13.3% | -38% | Stock Analytics | |
TIERRA AGROTECH | ₹408.2 Cr | 6.5% | 3.3% | -36.9% | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 2.4% |
9.4% |
9.8% |
SENSEX | 3.3% |
-0.1% |
21.8% |
You may also like the below Video Courses